Department of Chemistry, Department of Molecular Biosciences, Chemistry of Life Processes Institute, and Center for Molecular Innovation and Drug Discovery, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113, USA.
Bioorg Med Chem Lett. 2013 Oct 15;23(20):5674-9. doi: 10.1016/j.bmcl.2013.08.034. Epub 2013 Aug 14.
To develop potent and selective nNOS inhibitors, new double-headed molecules with chiral linkers that derive from natural amino acids or their derivatives have been designed. The new structures contain two ether bonds, which greatly simplifies the synthesis and accelerates structure optimization. Inhibitor (R)-6b exhibits a potency of 32nM against nNOS and is 475 and 244 more selective for nNOS over eNOS and iNOS, respectively. Crystal structures show that the additional binding between the aminomethyl moiety of 6b and the two heme propionates in nNOS, but not eNOS, is the structural basis for its high selectivity. This work demonstrates the importance of stereochemistry in this class of molecules, which significantly influences the potency and selectivity of the inhibitors. The structure-activity information gathered here provides a guide for future structure optimization.
为了开发强效且选择性的 nNOS 抑制剂,我们设计了新的双头分子,它们具有源自天然氨基酸或其衍生物的手性连接子。这些新结构包含两个醚键,这大大简化了合成并加速了结构优化。抑制剂 (R)-6b 对 nNOS 的抑制活性为 32nM,对 eNOS 和 iNOS 的选择性分别比 nNOS 高 475 倍和 244 倍。晶体结构表明,6b 的氨基甲基部分与 nNOS 中两个血红素丙酸之间的额外结合,但不是 eNOS,是其高选择性的结构基础。这项工作表明立体化学在这类分子中的重要性,它显著影响抑制剂的活性和选择性。这里收集的结构活性信息为未来的结构优化提供了指导。